Novartis AG (NVS)
158.00
-0.86
(-0.54%)
USD |
NYSE |
Aug 24, 16:00
158.00
0.00 (0.00%)
After-Hours: 20:00
Novartis 1 Year Total Returns (Daily) : 29.08% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 29.08% |
| August 20, 2026 | 26.52% |
| August 19, 2026 | 32.20% |
| August 18, 2026 | 28.42% |
| August 17, 2026 | 26.07% |
| August 14, 2026 | 27.34% |
| August 13, 2026 | 28.99% |
| August 12, 2026 | 31.55% |
| August 11, 2026 | 34.39% |
| August 10, 2026 | 38.27% |
| August 07, 2026 | 38.96% |
| August 06, 2026 | 40.00% |
| August 05, 2026 | 35.17% |
| August 04, 2026 | 34.03% |
| August 03, 2026 | 37.33% |
| July 31, 2026 | 41.46% |
| July 30, 2026 | 39.98% |
| July 29, 2026 | 39.62% |
| July 28, 2026 | 41.77% |
| July 27, 2026 | 36.67% |
| July 24, 2026 | 35.98% |
| July 23, 2026 | 36.38% |
| July 22, 2026 | 35.01% |
| July 21, 2026 | 38.91% |
| July 20, 2026 | 34.89% |
| Date | Value |
|---|---|
| July 17, 2026 | 38.35% |
| July 16, 2026 | 32.95% |
| July 15, 2026 | 29.85% |
| July 14, 2026 | 28.00% |
| July 13, 2026 | 30.59% |
| July 10, 2026 | 28.29% |
| July 09, 2026 | 29.60% |
| July 08, 2026 | 31.40% |
| July 07, 2026 | 32.50% |
| July 06, 2026 | 31.44% |
| July 02, 2026 | 33.08% |
| July 01, 2026 | 29.02% |
| June 30, 2026 | 33.45% |
| June 29, 2026 | 35.31% |
| June 26, 2026 | 33.09% |
| June 25, 2026 | 35.46% |
| June 24, 2026 | 32.78% |
| June 23, 2026 | 34.48% |
| June 22, 2026 | 32.56% |
| June 18, 2026 | 30.70% |
| June 17, 2026 | 33.55% |
| June 16, 2026 | 31.70% |
| June 15, 2026 | 30.74% |
| June 12, 2026 | 30.60% |
| June 11, 2026 | 34.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Roche Holding AG | 48.07% |
| AstraZeneca PLC | 4.92% |
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Merck & Co., Inc. | 83.18% |